

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 5.64435846 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 5.64435846 |
| 3 | protein localization to endosome (GO:0036010) | 5.23670556 |
| 4 | response to redox state (GO:0051775) | 5.11881013 |
| 5 | nerve growth factor signaling pathway (GO:0038180) | 4.98589348 |
| 6 | neuronal action potential propagation (GO:0019227) | 4.82330358 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.33558030 |
| 8 | synaptic vesicle maturation (GO:0016188) | 4.18109693 |
| 9 | layer formation in cerebral cortex (GO:0021819) | 4.08639643 |
| 10 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.07515470 |
| 11 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.03228157 |
| 12 | ensheathment of neurons (GO:0007272) | 3.96400709 |
| 13 | axon ensheathment (GO:0008366) | 3.96400709 |
| 14 | response to nerve growth factor (GO:1990089) | 3.93908315 |
| 15 | cellular response to nerve growth factor stimulus (GO:1990090) | 3.93908315 |
| 16 | mating behavior (GO:0007617) | 3.92609404 |
| 17 | myelination (GO:0042552) | 3.92377288 |
| 18 | apical protein localization (GO:0045176) | 3.91633534 |
| 19 | detection of molecule of bacterial origin (GO:0032490) | 3.87316164 |
| 20 | adult walking behavior (GO:0007628) | 3.84787784 |
| 21 | positive regulation by symbiont of host defense response (GO:0052509) | 3.83121861 |
| 22 | modulation by symbiont of host defense response (GO:0052031) | 3.83121861 |
| 23 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.83121861 |
| 24 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.83121861 |
| 25 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.83121861 |
| 26 | modulation by symbiont of host immune response (GO:0052553) | 3.83121861 |
| 27 | neuron remodeling (GO:0016322) | 3.80910005 |
| 28 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.78334628 |
| 29 | membrane tubulation (GO:0097320) | 3.61038525 |
| 30 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.52336972 |
| 31 | fatty acid elongation (GO:0030497) | 3.51139704 |
| 32 | locomotory exploration behavior (GO:0035641) | 3.47954967 |
| 33 | regulation of axon regeneration (GO:0048679) | 3.41766307 |
| 34 | regulation of neuron projection regeneration (GO:0070570) | 3.41766307 |
| 35 | macrophage activation involved in immune response (GO:0002281) | 3.41388613 |
| 36 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.39014843 |
| 37 | protein kinase C signaling (GO:0070528) | 3.37683973 |
| 38 | response to hydroperoxide (GO:0033194) | 3.36966019 |
| 39 | regulation of gamma-delta T cell activation (GO:0046643) | 3.35237546 |
| 40 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.31521761 |
| 41 | B cell receptor signaling pathway (GO:0050853) | 3.30107359 |
| 42 | cellular response to ethanol (GO:0071361) | 3.29328896 |
| 43 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 3.29095861 |
| 44 | negative regulation of neurotransmitter transport (GO:0051589) | 3.28975374 |
| 45 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.28231130 |
| 46 | leukotriene biosynthetic process (GO:0019370) | 3.27424199 |
| 47 | L-amino acid import (GO:0043092) | 3.22126810 |
| 48 | microglial cell activation (GO:0001774) | 3.21860979 |
| 49 | myelin maintenance (GO:0043217) | 3.21055946 |
| 50 | magnesium ion transport (GO:0015693) | 3.19879387 |
| 51 | cellular copper ion homeostasis (GO:0006878) | 3.16542483 |
| 52 | asymmetric protein localization (GO:0008105) | 3.16413458 |
| 53 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.15590809 |
| 54 | cellular response to interleukin-15 (GO:0071350) | 3.15100618 |
| 55 | clathrin coat assembly (GO:0048268) | 3.14892485 |
| 56 | response to vitamin E (GO:0033197) | 3.11545933 |
| 57 | negative regulation of interleukin-12 production (GO:0032695) | 3.10876643 |
| 58 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.08073644 |
| 59 | hepatocyte apoptotic process (GO:0097284) | 3.07146062 |
| 60 | regulation of receptor binding (GO:1900120) | 3.06762584 |
| 61 | regulation of synaptic vesicle transport (GO:1902803) | 3.06700240 |
| 62 | phospholipid translocation (GO:0045332) | 3.06033125 |
| 63 | lipid translocation (GO:0034204) | 3.06033125 |
| 64 | establishment of mitochondrion localization (GO:0051654) | 3.01842642 |
| 65 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.00973784 |
| 66 | T cell migration (GO:0072678) | 3.00042963 |
| 67 | cortical actin cytoskeleton organization (GO:0030866) | 2.99533854 |
| 68 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.98849780 |
| 69 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.96768516 |
| 70 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.95873844 |
| 71 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.95211367 |
| 72 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.95110417 |
| 73 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.94128017 |
| 74 | vesicle targeting (GO:0006903) | 2.91637882 |
| 75 | response to interleukin-15 (GO:0070672) | 2.89986977 |
| 76 | positive regulation of B cell differentiation (GO:0045579) | 2.89457994 |
| 77 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.89208196 |
| 78 | mannose metabolic process (GO:0006013) | 2.88476932 |
| 79 | glutamate secretion (GO:0014047) | 2.87773574 |
| 80 | interkinetic nuclear migration (GO:0022027) | 2.87579145 |
| 81 | neuron cell-cell adhesion (GO:0007158) | 2.87414226 |
| 82 | membrane assembly (GO:0071709) | 2.87154601 |
| 83 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.86757650 |
| 84 | response to host immune response (GO:0052572) | 2.86757650 |
| 85 | dendrite morphogenesis (GO:0048813) | 2.86179708 |
| 86 | membrane raft organization (GO:0031579) | 2.85748511 |
| 87 | histone H3-K36 demethylation (GO:0070544) | 2.84141792 |
| 88 | synaptic vesicle exocytosis (GO:0016079) | 2.83715079 |
| 89 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.83443858 |
| 90 | regulation of ARF GTPase activity (GO:0032312) | 2.81935103 |
| 91 | positive regulation of macroautophagy (GO:0016239) | 2.80576830 |
| 92 | protein localization to synapse (GO:0035418) | 2.80160255 |
| 93 | astrocyte development (GO:0014002) | 2.79714913 |
| 94 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.78677430 |
| 95 | import into cell (GO:0098657) | 2.77010552 |
| 96 | negative regulation of B cell proliferation (GO:0030889) | 2.76815803 |
| 97 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.75726830 |
| 98 | glycosylceramide metabolic process (GO:0006677) | 2.73222880 |
| 99 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.73033598 |
| 100 | response to lipoprotein particle (GO:0055094) | 2.72923020 |
| 101 | response to peptidoglycan (GO:0032494) | 2.72300639 |
| 102 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.71643407 |
| 103 | T-helper cell differentiation (GO:0042093) | 2.71506574 |
| 104 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.71506574 |
| 105 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.70027329 |
| 106 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.69607910 |
| 107 | response to host (GO:0075136) | 2.69408103 |
| 108 | response to host defenses (GO:0052200) | 2.69408103 |
| 109 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.69408103 |
| 110 | creatine metabolic process (GO:0006600) | 2.68296838 |
| 111 | cortical cytoskeleton organization (GO:0030865) | 2.67373238 |
| 112 | organelle transport along microtubule (GO:0072384) | 2.66718748 |
| 113 | negative regulation of cell killing (GO:0031342) | 2.64593789 |
| 114 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.64593789 |
| 115 | positive T cell selection (GO:0043368) | 2.63564468 |
| 116 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.63001204 |
| 117 | semaphorin-plexin signaling pathway (GO:0071526) | 2.61965456 |
| 118 | transepithelial transport (GO:0070633) | 2.61825230 |
| 119 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 2.61591056 |
| 120 | gamma-aminobutyric acid transport (GO:0015812) | 2.61160901 |
| 121 | negative regulation of axonogenesis (GO:0050771) | 2.61103960 |
| 122 | macrophage activation (GO:0042116) | 2.60950175 |
| 123 | regulation of necroptotic process (GO:0060544) | 2.60863836 |
| 124 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.60597891 |
| 125 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.60597891 |
| 126 | negative regulation of heart rate (GO:0010459) | 2.59635093 |
| 127 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.59045819 |
| 128 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.58857164 |
| 129 | cellular extravasation (GO:0045123) | 2.58770122 |
| 130 | neuromuscular process controlling balance (GO:0050885) | 2.56996330 |
| 131 | vesicle transport along microtubule (GO:0047496) | 2.56237450 |
| 132 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.55209994 |
| 133 | glutamate receptor signaling pathway (GO:0007215) | 2.53576337 |
| 134 | dendritic spine morphogenesis (GO:0060997) | 2.53409154 |
| 135 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.53362802 |
| 136 | axon development (GO:0061564) | 2.52971521 |
| 137 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.52899043 |
| 138 | regulation of B cell differentiation (GO:0045577) | 2.51960668 |
| 139 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.51529449 |
| 140 | mature B cell differentiation (GO:0002335) | 2.50881008 |
| 141 | leukotriene metabolic process (GO:0006691) | 2.48394294 |
| 142 | protein palmitoylation (GO:0018345) | 2.47851627 |
| 143 | positive thymic T cell selection (GO:0045059) | 2.45914773 |
| 144 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.45260971 |
| 145 | copper ion homeostasis (GO:0055070) | 2.45204410 |
| 146 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.44801963 |
| 147 | suckling behavior (GO:0001967) | 2.44479490 |
| 148 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.43964344 |
| 149 | neuron recognition (GO:0008038) | 2.43336444 |
| 150 | regulation of T cell tolerance induction (GO:0002664) | 2.42992997 |
| 151 | Rap protein signal transduction (GO:0032486) | 2.42586020 |
| 152 | replicative senescence (GO:0090399) | 2.42320758 |
| 153 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.41768890 |
| 154 | myeloid cell activation involved in immune response (GO:0002275) | 2.41199407 |
| 155 | Golgi to endosome transport (GO:0006895) | 2.40442282 |
| 156 | detection of external biotic stimulus (GO:0098581) | 2.39691485 |
| 157 | transmission of nerve impulse (GO:0019226) | 2.39402698 |
| 158 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.38690959 |
| 159 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.38390758 |
| 160 | L-serine transport (GO:0015825) | 2.37762084 |
| 161 | stress fiber assembly (GO:0043149) | 2.37508259 |
| 162 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.37470924 |
| 163 | B cell homeostasis (GO:0001782) | 2.37380537 |
| 164 | positive regulation of regulated secretory pathway (GO:1903307) | 2.36708256 |
| 165 | regulation of tolerance induction (GO:0002643) | 2.35747269 |
| 166 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.35732786 |
| 167 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.35732786 |
| 168 | T cell differentiation involved in immune response (GO:0002292) | 2.35732786 |
| 169 | negative T cell selection (GO:0043383) | 2.35292270 |
| 170 | positive regulation of interferon-alpha production (GO:0032727) | 2.34978563 |
| 171 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.34903283 |
| 172 | negative regulation of interleukin-17 production (GO:0032700) | 2.33445908 |
| 173 | cytidine metabolic process (GO:0046087) | 2.32973461 |
| 174 | cytidine catabolic process (GO:0006216) | 2.32973461 |
| 175 | cytidine deamination (GO:0009972) | 2.32973461 |
| 176 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.32911913 |
| 177 | interferon-gamma production (GO:0032609) | 2.31450772 |
| 178 | iron ion import (GO:0097286) | 2.30852499 |
| 179 | positive regulation of tolerance induction (GO:0002645) | 2.29580725 |
| 180 | neutrophil activation involved in immune response (GO:0002283) | 2.27619551 |
| 181 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.27162530 |
| 182 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.26986386 |
| 183 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.24729844 |
| 184 | regulation of interferon-alpha production (GO:0032647) | 2.24481292 |
| 185 | definitive hemopoiesis (GO:0060216) | 2.24408034 |
| 186 | protein targeting to vacuole (GO:0006623) | 2.24227737 |
| 187 | protein targeting to lysosome (GO:0006622) | 2.24227737 |
| 188 | establishment of protein localization to vacuole (GO:0072666) | 2.24227737 |
| 189 | T cell costimulation (GO:0031295) | 2.24161136 |
| 190 | peptide catabolic process (GO:0043171) | 2.24016400 |
| 191 | regulation of B cell proliferation (GO:0030888) | 2.23312845 |
| 192 | regulation of establishment of cell polarity (GO:2000114) | 2.23129698 |
| 193 | response to muramyl dipeptide (GO:0032495) | 2.22629348 |
| 194 | negative thymic T cell selection (GO:0045060) | 2.21160085 |
| 195 | positive regulation of leukocyte degranulation (GO:0043302) | 2.20980093 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.38617373 |
| 2 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.30892712 |
| 3 | GATA1_22025678_ChIP-Seq_K562_Human | 2.86999074 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.73063866 |
| 5 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.66853637 |
| 6 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 2.51260763 |
| 7 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.39380550 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.16613506 |
| 9 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.13024569 |
| 10 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.07397452 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.02947786 |
| 12 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.02028616 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.01846923 |
| 14 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.99370669 |
| 15 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.96746743 |
| 16 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.95616370 |
| 17 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.94977947 |
| 18 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.93909501 |
| 19 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.92438672 |
| 20 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.87542054 |
| 21 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.87110865 |
| 22 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.86254963 |
| 23 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.82400826 |
| 24 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.81970571 |
| 25 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.80898933 |
| 26 | MYB_26560356_Chip-Seq_TH2_Human | 1.78157351 |
| 27 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.77740319 |
| 28 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.77740319 |
| 29 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.75599989 |
| 30 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.74246064 |
| 31 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.73693809 |
| 32 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.70543289 |
| 33 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.64410726 |
| 34 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.63411161 |
| 35 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.59561762 |
| 36 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.58751897 |
| 37 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.57747149 |
| 38 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.57537602 |
| 39 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.57244430 |
| 40 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.54788816 |
| 41 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.54582103 |
| 42 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.53439233 |
| 43 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.52646496 |
| 44 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.50810325 |
| 45 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.49499320 |
| 46 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.48681204 |
| 47 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.48599471 |
| 48 | KDM2B_26808549_Chip-Seq_K562_Human | 1.47169214 |
| 49 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.47153779 |
| 50 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.47011303 |
| 51 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.44918648 |
| 52 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.43752421 |
| 53 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.42637226 |
| 54 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.39795166 |
| 55 | MYB_26560356_Chip-Seq_TH1_Human | 1.39117523 |
| 56 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.38967189 |
| 57 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.38692178 |
| 58 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.38027416 |
| 59 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.36957267 |
| 60 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.36431372 |
| 61 | SPI1_23127762_ChIP-Seq_K562_Human | 1.35607587 |
| 62 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.34201257 |
| 63 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.33946060 |
| 64 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.33945541 |
| 65 | TP53_16413492_ChIP-PET_HCT116_Human | 1.32004039 |
| 66 | GATA1_19941826_ChIP-Seq_K562_Human | 1.29276329 |
| 67 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.29045264 |
| 68 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.28894516 |
| 69 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.26223871 |
| 70 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.25946410 |
| 71 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.25557147 |
| 72 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.24997756 |
| 73 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23664171 |
| 74 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22630489 |
| 75 | RXR_22108803_ChIP-Seq_LS180_Human | 1.21793851 |
| 76 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.20630974 |
| 77 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.20205207 |
| 78 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.18795604 |
| 79 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.17876947 |
| 80 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.16460110 |
| 81 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.15742991 |
| 82 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.15590945 |
| 83 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.15426527 |
| 84 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.15426527 |
| 85 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.14290581 |
| 86 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.13361975 |
| 87 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.13181513 |
| 88 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.13079321 |
| 89 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.12762524 |
| 90 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.12693136 |
| 91 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.12668528 |
| 92 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.12295892 |
| 93 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.10036814 |
| 94 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.09776782 |
| 95 | GATA2_19941826_ChIP-Seq_K562_Human | 1.09406808 |
| 96 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.08588025 |
| 97 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.08505305 |
| 98 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.08225904 |
| 99 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.07987882 |
| 100 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.07832322 |
| 101 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.07793606 |
| 102 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.07732432 |
| 103 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.07632214 |
| 104 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.05369426 |
| 105 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.04815045 |
| 106 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.04652606 |
| 107 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.03639675 |
| 108 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.03015143 |
| 109 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.02193709 |
| 110 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.02180533 |
| 111 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01966646 |
| 112 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.01514271 |
| 113 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.01121741 |
| 114 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.00646675 |
| 115 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.00622995 |
| 116 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.00558181 |
| 117 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.00420623 |
| 118 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00105388 |
| 119 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.99340315 |
| 120 | TCF4_23295773_ChIP-Seq_U87_Human | 0.98926965 |
| 121 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.97983461 |
| 122 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.97941218 |
| 123 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.97425243 |
| 124 | MAF_26560356_Chip-Seq_TH1_Human | 0.96818698 |
| 125 | CJUN_26792858_Chip-Seq_BT549_Human | 0.96020429 |
| 126 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.95709849 |
| 127 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.95623084 |
| 128 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.95549462 |
| 129 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.95091432 |
| 130 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.94778015 |
| 131 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.94283818 |
| 132 | KDM2B_26808549_Chip-Seq_REH_Human | 0.94173493 |
| 133 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.93265927 |
| 134 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.92667339 |
| 135 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.91613802 |
| 136 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.90895794 |
| 137 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.90842680 |
| 138 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89859441 |
| 139 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.88950750 |
| 140 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.88792467 |
| 141 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.88642653 |
| 142 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.88391014 |
| 143 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.88373335 |
| 144 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.87953229 |
| 145 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.87924514 |
| 146 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.85895618 |
| 147 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.84207150 |
| 148 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.83831791 |
| 149 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83061539 |
| 150 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.82003872 |
| 151 | GATA3_26560356_Chip-Seq_TH2_Human | 0.77586907 |
| 152 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.75791665 |
| 153 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.75574461 |
| 154 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.75315030 |
| 155 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.75305475 |
| 156 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.74949512 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003329_amyloid_beta_deposits | 4.72365869 |
| 2 | MP0004270_analgesia | 4.36945615 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 4.09447953 |
| 4 | MP0000920_abnormal_myelination | 3.73422083 |
| 5 | MP0000604_amyloidosis | 3.29836106 |
| 6 | MP0003303_peritoneal_inflammation | 3.26728145 |
| 7 | MP0001835_abnormal_antigen_presentation | 3.05891875 |
| 8 | MP0008057_abnormal_DNA_replication | 2.88953281 |
| 9 | MP0003690_abnormal_glial_cell | 2.85683672 |
| 10 | MP0003172_abnormal_lysosome_physiology | 2.55190470 |
| 11 | MP0005671_abnormal_response_to | 2.51802143 |
| 12 | MP0003880_abnormal_central_pattern | 2.43346726 |
| 13 | MP0003635_abnormal_synaptic_transmissio | 2.36570182 |
| 14 | MP0002877_abnormal_melanocyte_morpholog | 2.32208242 |
| 15 | MP0003763_abnormal_thymus_physiology | 2.27708534 |
| 16 | MP0003724_increased_susceptibility_to | 2.26227993 |
| 17 | MP0009046_muscle_twitch | 2.25393728 |
| 18 | MP0001501_abnormal_sleep_pattern | 2.22154592 |
| 19 | MP0008260_abnormal_autophagy | 2.13735317 |
| 20 | MP0002064_seizures | 2.11198477 |
| 21 | MP0000778_abnormal_nervous_system | 2.06174672 |
| 22 | MP0000015_abnormal_ear_pigmentation | 2.02246115 |
| 23 | MP0003634_abnormal_glial_cell | 2.00145055 |
| 24 | MP0001968_abnormal_touch/_nociception | 1.99640299 |
| 25 | MP0004858_abnormal_nervous_system | 1.98708913 |
| 26 | MP0002272_abnormal_nervous_system | 1.95882178 |
| 27 | MP0002009_preneoplasia | 1.94736911 |
| 28 | MP0002166_altered_tumor_susceptibility | 1.91607362 |
| 29 | MP0003632_abnormal_nervous_system | 1.89890985 |
| 30 | MP0005058_abnormal_lysosome_morphology | 1.88508873 |
| 31 | MP0002734_abnormal_mechanical_nocicepti | 1.88315746 |
| 32 | MP0001299_abnormal_eye_distance/ | 1.78394901 |
| 33 | MP0002148_abnormal_hypersensitivity_rea | 1.77214425 |
| 34 | MP0000371_diluted_coat_color | 1.77032336 |
| 35 | MP0004381_abnormal_hair_follicle | 1.75760764 |
| 36 | MP0004885_abnormal_endolymph | 1.74531697 |
| 37 | MP0003045_fibrosis | 1.72202019 |
| 38 | MP0005025_abnormal_response_to | 1.71482270 |
| 39 | MP0003828_pulmonary_edema | 1.71415353 |
| 40 | MP0009785_altered_susceptibility_to | 1.70434920 |
| 41 | MP0009745_abnormal_behavioral_response | 1.69333090 |
| 42 | MP0002998_abnormal_bone_remodeling | 1.67805963 |
| 43 | MP0001958_emphysema | 1.67552479 |
| 44 | MP0002063_abnormal_learning/memory/cond | 1.65502825 |
| 45 | MP0003436_decreased_susceptibility_to | 1.62575749 |
| 46 | MP0002398_abnormal_bone_marrow | 1.59636097 |
| 47 | MP0000716_abnormal_immune_system | 1.58952953 |
| 48 | MP0000569_abnormal_digit_pigmentation | 1.57557530 |
| 49 | MP0005310_abnormal_salivary_gland | 1.56042044 |
| 50 | MP0005409_darkened_coat_color | 1.55462430 |
| 51 | MP0002405_respiratory_system_inflammati | 1.54691306 |
| 52 | MP0000751_myopathy | 1.54501225 |
| 53 | MP0004130_abnormal_muscle_cell | 1.53255395 |
| 54 | MP0004808_abnormal_hematopoietic_stem | 1.52108056 |
| 55 | MP0010678_abnormal_skin_adnexa | 1.49033010 |
| 56 | MP0003300_gastrointestinal_ulcer | 1.48863576 |
| 57 | MP0010155_abnormal_intestine_physiology | 1.47491590 |
| 58 | MP0001486_abnormal_startle_reflex | 1.44642551 |
| 59 | MP0005464_abnormal_platelet_physiology | 1.43079788 |
| 60 | MP0000689_abnormal_spleen_morphology | 1.40751186 |
| 61 | MP0005623_abnormal_meninges_morphology | 1.40340422 |
| 62 | MP0002572_abnormal_emotion/affect_behav | 1.40108468 |
| 63 | MP0003279_aneurysm | 1.36793202 |
| 64 | MP0003631_nervous_system_phenotype | 1.36563668 |
| 65 | MP0000955_abnormal_spinal_cord | 1.36006813 |
| 66 | MP0002006_tumorigenesis | 1.34932743 |
| 67 | MP0001853_heart_inflammation | 1.34464513 |
| 68 | MP0008438_abnormal_cutaneous_collagen | 1.33022270 |
| 69 | MP0004142_abnormal_muscle_tone | 1.29875587 |
| 70 | MP0002733_abnormal_thermal_nociception | 1.29484543 |
| 71 | MP0002722_abnormal_immune_system | 1.28482118 |
| 72 | MP0000383_abnormal_hair_follicle | 1.28460609 |
| 73 | MP0002396_abnormal_hematopoietic_system | 1.26686836 |
| 74 | * MP0002229_neurodegeneration | 1.24403743 |
| 75 | MP0001970_abnormal_pain_threshold | 1.23651617 |
| 76 | MP0006054_spinal_hemorrhage | 1.22642878 |
| 77 | MP0001873_stomach_inflammation | 1.21064739 |
| 78 | MP0002067_abnormal_sensory_capabilities | 1.21055488 |
| 79 | MP0001533_abnormal_skeleton_physiology | 1.20987000 |
| 80 | MP0008569_lethality_at_weaning | 1.20784155 |
| 81 | MP0004264_abnormal_extraembryonic_tissu | 1.19593800 |
| 82 | MP0009780_abnormal_chondrocyte_physiolo | 1.18834147 |
| 83 | MP0002254_reproductive_system_inflammat | 1.18442326 |
| 84 | MP0000372_irregular_coat_pigmentation | 1.18405011 |
| 85 | MP0003633_abnormal_nervous_system | 1.16965963 |
| 86 | MP0004811_abnormal_neuron_physiology | 1.16363291 |
| 87 | MP0002429_abnormal_blood_cell | 1.16056767 |
| 88 | MP0004924_abnormal_behavior | 1.15256799 |
| 89 | MP0005386_behavior/neurological_phenoty | 1.15256799 |
| 90 | MP0000747_muscle_weakness | 1.15251631 |
| 91 | MP0001845_abnormal_inflammatory_respons | 1.13022705 |
| 92 | MP0002066_abnormal_motor_capabilities/c | 1.12180178 |
| 93 | MP0000703_abnormal_thymus_morphology | 1.10920501 |
| 94 | MP0009764_decreased_sensitivity_to | 1.10176087 |
| 95 | * MP0002882_abnormal_neuron_morphology | 1.09809205 |
| 96 | MP0001440_abnormal_grooming_behavior | 1.09760886 |
| 97 | MP0004185_abnormal_adipocyte_glucose | 1.09556589 |
| 98 | MP0003091_abnormal_cell_migration | 1.08791585 |
| 99 | MP0002909_abnormal_adrenal_gland | 1.08363378 |
| 100 | MP0003075_altered_response_to | 1.07882068 |
| 101 | MP0003950_abnormal_plasma_membrane | 1.07422560 |
| 102 | MP0009333_abnormal_splenocyte_physiolog | 1.07344887 |
| 103 | MP0002138_abnormal_hepatobiliary_system | 1.03831264 |
| 104 | MP0005423_abnormal_somatic_nervous | 1.03073628 |
| 105 | MP0005075_abnormal_melanosome_morpholog | 1.00570273 |
| 106 | MP0003866_abnormal_defecation | 1.00396190 |
| 107 | MP0005171_absent_coat_pigmentation | 0.97411299 |
| 108 | MP0010352_gastrointestinal_tract_polyps | 0.97386618 |
| 109 | MP0004883_abnormal_blood_vessel | 0.97142900 |
| 110 | MP0004947_skin_inflammation | 0.96513313 |
| 111 | MP0000858_altered_metastatic_potential | 0.95893727 |
| 112 | MP0003191_abnormal_cellular_cholesterol | 0.95496237 |
| 113 | MP0004510_myositis | 0.94588698 |
| 114 | MP0000685_abnormal_immune_system | 0.94223167 |
| 115 | MP0001851_eye_inflammation | 0.91607361 |
| 116 | MP0004484_altered_response_of | 0.90818158 |
| 117 | MP0005388_respiratory_system_phenotype | 0.90511716 |
| 118 | MP0002133_abnormal_respiratory_system | 0.90511716 |
| 119 | MP0002933_joint_inflammation | 0.89958488 |
| 120 | MP0005387_immune_system_phenotype | 0.89779210 |
| 121 | MP0001790_abnormal_immune_system | 0.89779210 |
| 122 | MP0002089_abnormal_postnatal_growth/wei | 0.89039969 |
| 123 | MP0003646_muscle_fatigue | 0.88204304 |
| 124 | MP0005164_abnormal_response_to | 0.87695520 |
| 125 | MP0003448_altered_tumor_morphology | 0.84304339 |
| 126 | MP0002075_abnormal_coat/hair_pigmentati | 0.83060153 |
| 127 | MP0006082_CNS_inflammation | 0.82671730 |
| 128 | MP0010307_abnormal_tumor_latency | 0.81410230 |
| 129 | MP0005257_abnormal_intraocular_pressure | 0.81138482 |
| 130 | MP0001905_abnormal_dopamine_level | 0.80621895 |
| 131 | MP0004742_abnormal_vestibular_system | 0.80061625 |
| 132 | MP0003221_abnormal_cardiomyocyte_apopto | 0.80022798 |
| 133 | MP0004134_abnormal_chest_morphology | 0.79942122 |
| 134 | MP0002184_abnormal_innervation | 0.79071503 |
| 135 | MP0002735_abnormal_chemical_nociception | 0.78557862 |
| 136 | MP0005275_abnormal_skin_tensile | 0.78275827 |
| 137 | * MP0003183_abnormal_peptide_metabolism | 0.77302490 |
| 138 | MP0002152_abnormal_brain_morphology | 0.76452106 |
| 139 | MP0005076_abnormal_cell_differentiation | 0.75819003 |
| 140 | MP0001177_atelectasis | 0.75205956 |
| 141 | MP0002332_abnormal_exercise_endurance | 0.73640115 |
| 142 | MP0005174_abnormal_tail_pigmentation | 0.73570155 |
| 143 | MP0005647_abnormal_sex_gland | 0.73206389 |
| 144 | MP0000465_gastrointestinal_hemorrhage | 0.72996868 |
| 145 | MP0004233_abnormal_muscle_weight | 0.72829602 |
| 146 | MP0009115_abnormal_fat_cell | 0.71904021 |
| 147 | MP0001485_abnormal_pinna_reflex | 0.71203783 |
| 148 | MP0001348_abnormal_lacrimal_gland | 0.70901235 |
| 149 | MP0000767_abnormal_smooth_muscle | 0.70855200 |
| 150 | MP0002419_abnormal_innate_immunity | 0.70270501 |
| 151 | MP0005397_hematopoietic_system_phenotyp | 0.69939180 |
| 152 | MP0001545_abnormal_hematopoietic_system | 0.69939180 |
| 153 | MP0008874_decreased_physiological_sensi | 0.66213657 |
| 154 | MP0001800_abnormal_humoral_immune | 0.64648487 |
| 155 | MP0003566_abnormal_cell_adhesion | 0.63387145 |
| 156 | MP0005000_abnormal_immune_tolerance | 0.61135919 |
| 157 | MP0002736_abnormal_nociception_after | 0.57940157 |
| 158 | MP0002971_abnormal_brown_adipose | 0.56614582 |
| 159 | MP0001943_abnormal_respiration | 0.55685735 |
| 160 | MP0002420_abnormal_adaptive_immunity | 0.53269734 |
| 161 | MP0002723_abnormal_immune_serum | 0.52865039 |
| 162 | MP0002452_abnormal_antigen_presenting | 0.51539578 |
| 163 | MP0001819_abnormal_immune_cell | 0.51092679 |
| 164 | MP0003656_abnormal_erythrocyte_physiolo | 0.50223314 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Neurofibrillary tangles (HP:0002185) | 7.30527551 |
| 2 | Cerebral inclusion bodies (HP:0100314) | 6.26591188 |
| 3 | Sensory axonal neuropathy (HP:0003390) | 5.29056648 |
| 4 | Papilledema (HP:0001085) | 5.22980703 |
| 5 | Supranuclear gaze palsy (HP:0000605) | 5.05778606 |
| 6 | T lymphocytopenia (HP:0005403) | 4.47611646 |
| 7 | Abnormality of T cell number (HP:0011839) | 4.04535623 |
| 8 | Spontaneous hematomas (HP:0007420) | 3.74158262 |
| 9 | Ankle clonus (HP:0011448) | 3.39213244 |
| 10 | Insidious onset (HP:0003587) | 3.32680000 |
| 11 | Termporal pattern (HP:0011008) | 3.32680000 |
| 12 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.31231918 |
| 13 | Neuronal loss in central nervous system (HP:0002529) | 3.28297798 |
| 14 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.23948075 |
| 15 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.23948075 |
| 16 | Dyschromatopsia (HP:0007641) | 3.20873121 |
| 17 | Submucous cleft hard palate (HP:0000176) | 3.19660887 |
| 18 | Myokymia (HP:0002411) | 3.16900053 |
| 19 | Peripheral hypomyelination (HP:0007182) | 3.13570372 |
| 20 | Abnormality of the corticospinal tract (HP:0002492) | 3.08366670 |
| 21 | Cerebral hemorrhage (HP:0001342) | 3.02318568 |
| 22 | Slow saccadic eye movements (HP:0000514) | 3.01215642 |
| 23 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.92296063 |
| 24 | Recurrent bacterial skin infections (HP:0005406) | 2.91054188 |
| 25 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.90972166 |
| 26 | Recurrent cutaneous fungal infections (HP:0011370) | 2.90972166 |
| 27 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.89073917 |
| 28 | Disinhibition (HP:0000734) | 2.88833539 |
| 29 | Eczematoid dermatitis (HP:0000976) | 2.83890345 |
| 30 | Alacrima (HP:0000522) | 2.81092288 |
| 31 | Chin dimple (HP:0010751) | 2.79932190 |
| 32 | Recurrent fungal infections (HP:0002841) | 2.75961202 |
| 33 | Action tremor (HP:0002345) | 2.75011808 |
| 34 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.74315123 |
| 35 | Dysmetria (HP:0001310) | 2.73932877 |
| 36 | Arterial tortuosity (HP:0005116) | 2.67385471 |
| 37 | Amyloidosis (HP:0011034) | 2.63021446 |
| 38 | Recurrent viral infections (HP:0004429) | 2.62851206 |
| 39 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.61630129 |
| 40 | Spastic gait (HP:0002064) | 2.59996741 |
| 41 | Resting tremor (HP:0002322) | 2.59316463 |
| 42 | Mutism (HP:0002300) | 2.56583975 |
| 43 | Onion bulb formation (HP:0003383) | 2.52952107 |
| 44 | Chronic diarrhea (HP:0002028) | 2.48379772 |
| 45 | Recurrent abscess formation (HP:0002722) | 2.47469260 |
| 46 | Abnormality of binocular vision (HP:0011514) | 2.45738134 |
| 47 | Diplopia (HP:0000651) | 2.45738134 |
| 48 | Urinary urgency (HP:0000012) | 2.45219209 |
| 49 | Rectal prolapse (HP:0002035) | 2.42496901 |
| 50 | Chest pain (HP:0100749) | 2.40109789 |
| 51 | * Broad ribs (HP:0000885) | 2.39310654 |
| 52 | Inappropriate behavior (HP:0000719) | 2.38267412 |
| 53 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.37520151 |
| 54 | Rapidly progressive (HP:0003678) | 2.37467059 |
| 55 | Mediastinal lymphadenopathy (HP:0100721) | 2.35929592 |
| 56 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.34967327 |
| 57 | Recurrent skin infections (HP:0001581) | 2.34247505 |
| 58 | Abnormality of T cells (HP:0002843) | 2.33889270 |
| 59 | Vascular tortuosity (HP:0004948) | 2.33425688 |
| 60 | Ureteral obstruction (HP:0006000) | 2.33210814 |
| 61 | Increased variability in muscle fiber diameter (HP:0003557) | 2.32817592 |
| 62 | Progressive cerebellar ataxia (HP:0002073) | 2.32204042 |
| 63 | Autoimmune hemolytic anemia (HP:0001890) | 2.31810063 |
| 64 | Abnormality of the fingertips (HP:0001211) | 2.31770374 |
| 65 | Choroideremia (HP:0001139) | 2.30191971 |
| 66 | Vasculitis (HP:0002633) | 2.26325790 |
| 67 | Pulmonary infiltrates (HP:0002113) | 2.25497268 |
| 68 | Distal arthrogryposis (HP:0005684) | 2.23589213 |
| 69 | Progressive inability to walk (HP:0002505) | 2.23123535 |
| 70 | Focal seizures (HP:0007359) | 2.22911621 |
| 71 | Spondylolisthesis (HP:0003302) | 2.22209307 |
| 72 | Thick nail (HP:0001805) | 2.20706430 |
| 73 | Absent frontal sinuses (HP:0002688) | 2.19753228 |
| 74 | Pheochromocytoma (HP:0002666) | 2.18771384 |
| 75 | Hemorrhage of the eye (HP:0011885) | 2.16766358 |
| 76 | Abnormality of macrophages (HP:0004311) | 2.16431920 |
| 77 | Autoimmune thrombocytopenia (HP:0001973) | 2.16041403 |
| 78 | Increased cerebral lipofuscin (HP:0011813) | 2.15951162 |
| 79 | * Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.14889959 |
| 80 | * Abnormality of glycolipid metabolism (HP:0010969) | 2.14889959 |
| 81 | * Abnormality of liposaccharide metabolism (HP:0010968) | 2.14889959 |
| 82 | Apathy (HP:0000741) | 2.14531431 |
| 83 | Visual hallucinations (HP:0002367) | 2.14259765 |
| 84 | Obstructive sleep apnea (HP:0002870) | 2.13706015 |
| 85 | Postural instability (HP:0002172) | 2.13211322 |
| 86 | Macroorchidism (HP:0000053) | 2.11949850 |
| 87 | Anomalous pulmonary venous return (HP:0010772) | 2.10820542 |
| 88 | Dysmetric saccades (HP:0000641) | 2.10293235 |
| 89 | Abnormal auditory evoked potentials (HP:0006958) | 2.09768907 |
| 90 | Generalized hypopigmentation of hair (HP:0011358) | 2.09126564 |
| 91 | Postural tremor (HP:0002174) | 2.08817355 |
| 92 | Hemoptysis (HP:0002105) | 2.05875343 |
| 93 | Akinesia (HP:0002304) | 2.05549721 |
| 94 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.05355570 |
| 95 | Intention tremor (HP:0002080) | 2.05097068 |
| 96 | Chronic otitis media (HP:0000389) | 2.04980776 |
| 97 | Decreased lacrimation (HP:0000633) | 2.04724255 |
| 98 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 2.03309940 |
| 99 | Abnormality of the pulmonary veins (HP:0011718) | 2.02810657 |
| 100 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 2.02053123 |
| 101 | Truncal ataxia (HP:0002078) | 2.01936920 |
| 102 | Gingivitis (HP:0000230) | 2.00594827 |
| 103 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.99834365 |
| 104 | Lower limb muscle weakness (HP:0007340) | 1.99784687 |
| 105 | Protruding tongue (HP:0010808) | 1.99228928 |
| 106 | Neuroendocrine neoplasm (HP:0100634) | 1.98698585 |
| 107 | Hyporeflexia of lower limbs (HP:0002600) | 1.97906271 |
| 108 | Gastrointestinal infarctions (HP:0005244) | 1.97194762 |
| 109 | Mask-like facies (HP:0000298) | 1.96471694 |
| 110 | Meningitis (HP:0001287) | 1.96059857 |
| 111 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.94737725 |
| 112 | Conjunctival telangiectasia (HP:0000524) | 1.93573873 |
| 113 | * Thoracolumbar scoliosis (HP:0002944) | 1.93101456 |
| 114 | Colitis (HP:0002583) | 1.91907945 |
| 115 | Aqueductal stenosis (HP:0002410) | 1.91398692 |
| 116 | Arterial thrombosis (HP:0004420) | 1.91050558 |
| 117 | Focal motor seizures (HP:0011153) | 1.90654671 |
| 118 | Dysdiadochokinesis (HP:0002075) | 1.90451949 |
| 119 | Periodontitis (HP:0000704) | 1.89099955 |
| 120 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.88737789 |
| 121 | Abnormality of saccadic eye movements (HP:0000570) | 1.88565384 |
| 122 | Axonal loss (HP:0003447) | 1.88422136 |
| 123 | * Dysostosis multiplex (HP:0000943) | 1.88296848 |
| 124 | Subacute progressive viral hepatitis (HP:0006572) | 1.88236427 |
| 125 | Hemiplegia (HP:0002301) | 1.87725236 |
| 126 | Restrictive lung disease (HP:0002091) | 1.87605707 |
| 127 | Genetic anticipation (HP:0003743) | 1.87413181 |
| 128 | Hyperthyroidism (HP:0000836) | 1.87321224 |
| 129 | Leukocytosis (HP:0001974) | 1.87075562 |
| 130 | Hypoplasia of the brainstem (HP:0002365) | 1.87029055 |
| 131 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.87029055 |
| 132 | Insomnia (HP:0100785) | 1.86871405 |
| 133 | EMG: myopathic abnormalities (HP:0003458) | 1.86813584 |
| 134 | Overgrowth (HP:0001548) | 1.85728069 |
| 135 | Achilles tendon contracture (HP:0001771) | 1.84953095 |
| 136 | Clumsiness (HP:0002312) | 1.84836378 |
| 137 | Bronchomalacia (HP:0002780) | 1.84599166 |
| 138 | Curly hair (HP:0002212) | 1.84185966 |
| 139 | Spastic tetraparesis (HP:0001285) | 1.83337972 |
| 140 | Papillary thyroid carcinoma (HP:0002895) | 1.83285938 |
| 141 | Hematochezia (HP:0002573) | 1.82955713 |
| 142 | Diminished motivation (HP:0000745) | 1.82740460 |
| 143 | Narrow palate (HP:0000189) | 1.82153945 |
| 144 | Retrobulbar optic neuritis (HP:0100654) | 1.81679510 |
| 145 | Optic neuritis (HP:0100653) | 1.81679510 |
| 146 | Agammaglobulinemia (HP:0004432) | 1.81437506 |
| 147 | Distal sensory impairment (HP:0002936) | 1.81385291 |
| 148 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.81165551 |
| 149 | Orchitis (HP:0100796) | 1.80172676 |
| 150 | Amaurosis fugax (HP:0100576) | 1.79308118 |
| 151 | IgA deficiency (HP:0002720) | 1.79274252 |
| 152 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.78556041 |
| 153 | Testicular atrophy (HP:0000029) | 1.77656077 |
| 154 | Clonus (HP:0002169) | 1.77089611 |
| 155 | Osteolytic defects of the hand bones (HP:0009699) | 1.77070454 |
| 156 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.77070454 |
| 157 | Bowel incontinence (HP:0002607) | 1.76994329 |
| 158 | Myositis (HP:0100614) | 1.76721144 |
| 159 | Viral hepatitis (HP:0006562) | 1.75942981 |
| 160 | Acute myeloid leukemia (HP:0004808) | 1.75897018 |
| 161 | Gaze-evoked nystagmus (HP:0000640) | 1.75222684 |
| 162 | Ocular albinism (HP:0001107) | 1.74872551 |
| 163 | Abnormal large intestine physiology (HP:0012700) | 1.74523598 |
| 164 | External ophthalmoplegia (HP:0000544) | 1.73865336 |
| 165 | Pustule (HP:0200039) | 1.73756238 |
| 166 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.73698984 |
| 167 | Pulmonary embolism (HP:0002204) | 1.73575582 |
| 168 | Cerebral aneurysm (HP:0004944) | 1.73280336 |
| 169 | Abnormality of the prostate (HP:0008775) | 1.72661115 |
| 170 | Increased CSF protein (HP:0002922) | 1.72346158 |
| 171 | Ureteral stenosis (HP:0000071) | 1.71957022 |
| 172 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.71017526 |
| 173 | Slender build (HP:0001533) | 1.71014154 |
| 174 | Persistence of primary teeth (HP:0006335) | 1.69637405 |
| 175 | Widely spaced teeth (HP:0000687) | 1.67956479 |
| 176 | Thrombocytosis (HP:0001894) | 1.67480866 |
| 177 | Coarse hair (HP:0002208) | 1.66900802 |
| 178 | Osteomyelitis (HP:0002754) | 1.66409730 |
| 179 | Sparse lateral eyebrow (HP:0005338) | 1.66376988 |
| 180 | Fair hair (HP:0002286) | 1.65277974 |
| 181 | Impaired smooth pursuit (HP:0007772) | 1.64476072 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK1 | 5.00824386 |
| 2 | STK39 | 3.21655753 |
| 3 | NME2 | 3.20523073 |
| 4 | PRPF4B | 2.99548130 |
| 5 | MAP4K1 | 2.84467848 |
| 6 | TXK | 2.80813104 |
| 7 | MAP3K9 | 2.56830817 |
| 8 | ICK | 2.49048139 |
| 9 | OXSR1 | 2.44686103 |
| 10 | EPHB1 | 2.41283502 |
| 11 | CAMK2D | 2.38304242 |
| 12 | RET | 2.21818442 |
| 13 | TGFBR2 | 2.17736188 |
| 14 | MAP3K14 | 2.14849622 |
| 15 | MARK1 | 2.13799331 |
| 16 | MAP2K3 | 2.07193206 |
| 17 | CDK12 | 1.92279556 |
| 18 | CAMKK2 | 1.90736804 |
| 19 | PNCK | 1.85200536 |
| 20 | LATS2 | 1.80651594 |
| 21 | PAK6 | 1.72922294 |
| 22 | JAK1 | 1.68785799 |
| 23 | GRK7 | 1.64070498 |
| 24 | SGK2 | 1.63426267 |
| 25 | FES | 1.60464046 |
| 26 | SYK | 1.57840686 |
| 27 | CDK19 | 1.57104215 |
| 28 | AKT3 | 1.56148255 |
| 29 | IRAK4 | 1.55890807 |
| 30 | DAPK2 | 1.52154861 |
| 31 | TRIB3 | 1.50862043 |
| 32 | NTRK3 | 1.50246087 |
| 33 | TEC | 1.49765183 |
| 34 | SIK2 | 1.45879579 |
| 35 | MATK | 1.43055845 |
| 36 | DAPK1 | 1.41284433 |
| 37 | FGFR3 | 1.40095802 |
| 38 | CAMK1G | 1.38436549 |
| 39 | CSK | 1.35888996 |
| 40 | FRK | 1.32956739 |
| 41 | IKBKE | 1.32375596 |
| 42 | MAP3K13 | 1.32312290 |
| 43 | PRKCQ | 1.31711915 |
| 44 | MAPKAPK5 | 1.30333776 |
| 45 | TYK2 | 1.28389261 |
| 46 | BMPR2 | 1.28024492 |
| 47 | ROCK2 | 1.25691285 |
| 48 | ACVR1B | 1.25477348 |
| 49 | CDK5 | 1.23437614 |
| 50 | SGK3 | 1.21771995 |
| 51 | IRAK1 | 1.21429727 |
| 52 | ALK | 1.19222339 |
| 53 | CSNK1A1L | 1.18487852 |
| 54 | JAK3 | 1.15787710 |
| 55 | TYRO3 | 1.15730539 |
| 56 | EPHA3 | 1.13896342 |
| 57 | ZAP70 | 1.13887285 |
| 58 | FGFR2 | 1.12978958 |
| 59 | CSNK1G2 | 1.12556181 |
| 60 | MAPKAPK3 | 1.11783455 |
| 61 | HCK | 1.11502697 |
| 62 | CSNK1G3 | 1.11494531 |
| 63 | NEK9 | 1.11101223 |
| 64 | KSR2 | 1.10688701 |
| 65 | CAMK4 | 1.06720219 |
| 66 | YES1 | 1.06405773 |
| 67 | PKN1 | 1.04506748 |
| 68 | PDPK1 | 1.01073001 |
| 69 | UHMK1 | 1.00961592 |
| 70 | TNIK | 0.98485787 |
| 71 | FGR | 0.96988690 |
| 72 | TRPM7 | 0.96612745 |
| 73 | MINK1 | 0.95499576 |
| 74 | LRRK2 | 0.95076933 |
| 75 | WNK1 | 0.94998300 |
| 76 | PRKCH | 0.92980208 |
| 77 | MET | 0.92639381 |
| 78 | JAK2 | 0.91624805 |
| 79 | CLK1 | 0.91542902 |
| 80 | FGFR4 | 0.91432909 |
| 81 | MAPK12 | 0.90556201 |
| 82 | NTRK2 | 0.90503114 |
| 83 | GRK6 | 0.90240134 |
| 84 | RIPK4 | 0.90072549 |
| 85 | ERN1 | 0.88695482 |
| 86 | CDK14 | 0.88669923 |
| 87 | PTK2B | 0.87011610 |
| 88 | TTN | 0.87010877 |
| 89 | FYN | 0.86454792 |
| 90 | CSNK1G1 | 0.85760099 |
| 91 | CSF1R | 0.85591031 |
| 92 | LCK | 0.84676415 |
| 93 | RIPK1 | 0.84091453 |
| 94 | IRAK2 | 0.82838702 |
| 95 | IKBKB | 0.82710612 |
| 96 | BTK | 0.81047176 |
| 97 | EPHB2 | 0.80321334 |
| 98 | LYN | 0.79560611 |
| 99 | PIK3CG | 0.78801737 |
| 100 | INSRR | 0.78210171 |
| 101 | SGK223 | 0.77885516 |
| 102 | SGK494 | 0.77885516 |
| 103 | ADRBK2 | 0.77113102 |
| 104 | CDK6 | 0.76720070 |
| 105 | LATS1 | 0.75089567 |
| 106 | PDK1 | 0.74133848 |
| 107 | TBK1 | 0.73197342 |
| 108 | EPHA4 | 0.72654193 |
| 109 | PHKG1 | 0.72062622 |
| 110 | PHKG2 | 0.72062622 |
| 111 | MAP3K6 | 0.71845752 |
| 112 | MAP3K3 | 0.70942354 |
| 113 | NLK | 0.70139730 |
| 114 | PKN2 | 0.69797089 |
| 115 | PLK2 | 0.69211246 |
| 116 | CAMKK1 | 0.69166456 |
| 117 | CHUK | 0.68836556 |
| 118 | MAP2K6 | 0.66816269 |
| 119 | EEF2K | 0.66057957 |
| 120 | MAP3K1 | 0.65320976 |
| 121 | CDK15 | 0.65113408 |
| 122 | SRC | 0.64198787 |
| 123 | LMTK2 | 0.63090193 |
| 124 | NEK6 | 0.62707608 |
| 125 | ABL1 | 0.61900936 |
| 126 | STK3 | 0.60503794 |
| 127 | CAMK1D | 0.59146062 |
| 128 | DMPK | 0.59075027 |
| 129 | BLK | 0.58170516 |
| 130 | CDK18 | 0.55965094 |
| 131 | PAK3 | 0.55911454 |
| 132 | PDGFRB | 0.55553265 |
| 133 | MAP2K4 | 0.55295238 |
| 134 | PIM1 | 0.54662603 |
| 135 | SGK1 | 0.54447875 |
| 136 | ITK | 0.54360654 |
| 137 | HIPK2 | 0.54278722 |
| 138 | MARK3 | 0.53694263 |
| 139 | MAP3K2 | 0.53338955 |
| 140 | TAOK3 | 0.52839456 |
| 141 | PAK2 | 0.51223904 |
| 142 | PRKCG | 0.50520333 |
| 143 | CDK11A | 0.50359193 |
| 144 | BRD4 | 0.50017072 |
| 145 | PIK3CA | 0.49740088 |
| 146 | PDGFRA | 0.49542586 |
| 147 | STK10 | 0.49406524 |
| 148 | TESK2 | 0.48528505 |
| 149 | INSR | 0.48073390 |
| 150 | PRKD1 | 0.47947352 |
| 151 | STK38 | 0.47528293 |
| 152 | MELK | 0.47198514 |
| 153 | MARK2 | 0.46562081 |
| 154 | MAP3K7 | 0.46033469 |
| 155 | SCYL2 | 0.45940081 |
| 156 | GRK5 | 0.45673378 |
| 157 | STK11 | 0.44975736 |
| 158 | MOS | 0.44841682 |
| 159 | CSNK1D | 0.44460107 |
| 160 | WNK4 | 0.43736908 |
| 161 | BCR | 0.42722876 |
| 162 | MAPK7 | 0.42571886 |
| 163 | ARAF | 0.42168539 |
| 164 | KIT | 0.41355454 |
| 165 | DAPK3 | 0.41163502 |
| 166 | BMX | 0.40810839 |
| 167 | LIMK1 | 0.39990410 |
| 168 | PRKCZ | 0.39061155 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.53205669 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.97710987 |
| 3 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.90744185 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.83596713 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.80964552 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 1.79169241 |
| 7 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.73273986 |
| 8 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.69538644 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.68573889 |
| 10 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.62338528 |
| 11 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.59795437 |
| 12 | Long-term potentiation_Homo sapiens_hsa04720 | 1.58087979 |
| 13 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.54333869 |
| 14 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.50806811 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 1.50174237 |
| 16 | Allograft rejection_Homo sapiens_hsa05330 | 1.49321712 |
| 17 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.48024250 |
| 18 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.46382583 |
| 19 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.43781751 |
| 20 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.43589158 |
| 21 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.43412485 |
| 22 | Axon guidance_Homo sapiens_hsa04360 | 1.42960897 |
| 23 | Long-term depression_Homo sapiens_hsa04730 | 1.41865858 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.40823240 |
| 25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.40436750 |
| 26 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.39469044 |
| 27 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.37760745 |
| 28 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.36695190 |
| 29 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.35445232 |
| 30 | GABAergic synapse_Homo sapiens_hsa04727 | 1.34044035 |
| 31 | Morphine addiction_Homo sapiens_hsa05032 | 1.32632437 |
| 32 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.32404749 |
| 33 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.28576448 |
| 34 | Salivary secretion_Homo sapiens_hsa04970 | 1.28411000 |
| 35 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.27357292 |
| 36 | Platelet activation_Homo sapiens_hsa04611 | 1.27104858 |
| 37 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.24890576 |
| 38 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.24074847 |
| 39 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.23315299 |
| 40 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.22703095 |
| 41 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.22553825 |
| 42 | Olfactory transduction_Homo sapiens_hsa04740 | 1.22501570 |
| 43 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.22144011 |
| 44 | Measles_Homo sapiens_hsa05162 | 1.21515378 |
| 45 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.20481077 |
| 46 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.18957839 |
| 47 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.18728246 |
| 48 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.18542307 |
| 49 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.18197494 |
| 50 | Circadian entrainment_Homo sapiens_hsa04713 | 1.17380440 |
| 51 | Endocytosis_Homo sapiens_hsa04144 | 1.17088333 |
| 52 | Asthma_Homo sapiens_hsa05310 | 1.16857418 |
| 53 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.16202979 |
| 54 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.15543204 |
| 55 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.15067077 |
| 56 | Renin secretion_Homo sapiens_hsa04924 | 1.13620642 |
| 57 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.13440684 |
| 58 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.13321162 |
| 59 | Influenza A_Homo sapiens_hsa05164 | 1.12000379 |
| 60 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.10285006 |
| 61 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.09144181 |
| 62 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.08967640 |
| 63 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.08734225 |
| 64 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.08719717 |
| 65 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.08087723 |
| 66 | Glioma_Homo sapiens_hsa05214 | 1.07329231 |
| 67 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.07194922 |
| 68 | * Lysosome_Homo sapiens_hsa04142 | 1.06556203 |
| 69 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.05877825 |
| 70 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.00333357 |
| 71 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.99545530 |
| 72 | Nicotine addiction_Homo sapiens_hsa05033 | 0.98894432 |
| 73 | Cocaine addiction_Homo sapiens_hsa05030 | 0.97916687 |
| 74 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.96910146 |
| 75 | Hepatitis B_Homo sapiens_hsa05161 | 0.96628576 |
| 76 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.96372343 |
| 77 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.93943685 |
| 78 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.93774846 |
| 79 | Hepatitis C_Homo sapiens_hsa05160 | 0.93483933 |
| 80 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.93191260 |
| 81 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.93062469 |
| 82 | Prostate cancer_Homo sapiens_hsa05215 | 0.92577621 |
| 83 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.90017285 |
| 84 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.89515190 |
| 85 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.89406581 |
| 86 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.88916741 |
| 87 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.88761667 |
| 88 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.87625505 |
| 89 | Gap junction_Homo sapiens_hsa04540 | 0.86303562 |
| 90 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.86075068 |
| 91 | Focal adhesion_Homo sapiens_hsa04510 | 0.85774820 |
| 92 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.85637977 |
| 93 | Endometrial cancer_Homo sapiens_hsa05213 | 0.85432727 |
| 94 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.85139201 |
| 95 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.84949340 |
| 96 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.83539075 |
| 97 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.82596442 |
| 98 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.82458453 |
| 99 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.82306751 |
| 100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.81289129 |
| 101 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.80539117 |
| 102 | Phagosome_Homo sapiens_hsa04145 | 0.80022760 |
| 103 | Other glycan degradation_Homo sapiens_hsa00511 | 0.79795249 |
| 104 | Viral myocarditis_Homo sapiens_hsa05416 | 0.79302416 |
| 105 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.79053241 |
| 106 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.78630155 |
| 107 | Amoebiasis_Homo sapiens_hsa05146 | 0.78286172 |
| 108 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.76882187 |
| 109 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75205381 |
| 110 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.74629858 |
| 111 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.74317786 |
| 112 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.73962979 |
| 113 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.73468972 |
| 114 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.72768973 |
| 115 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.71569920 |
| 116 | Salmonella infection_Homo sapiens_hsa05132 | 0.70874864 |
| 117 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.70767037 |
| 118 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.70603624 |
| 119 | Tuberculosis_Homo sapiens_hsa05152 | 0.70603257 |
| 120 | Insulin resistance_Homo sapiens_hsa04931 | 0.69149596 |
| 121 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.66779903 |
| 122 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.66710223 |
| 123 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.66577251 |
| 124 | Malaria_Homo sapiens_hsa05144 | 0.66117896 |
| 125 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.65672651 |
| 126 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.65509975 |
| 127 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.65426738 |
| 128 | HTLV-I infection_Homo sapiens_hsa05166 | 0.64787876 |
| 129 | Tight junction_Homo sapiens_hsa04530 | 0.64537038 |
| 130 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.64159268 |
| 131 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.64081398 |
| 132 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.62956768 |
| 133 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.62594466 |
| 134 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.60997871 |
| 135 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.60908107 |
| 136 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.60563551 |
| 137 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.60269071 |
| 138 | Thyroid cancer_Homo sapiens_hsa05216 | 0.60066004 |
| 139 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.59327852 |
| 140 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.59306849 |
| 141 | Apoptosis_Homo sapiens_hsa04210 | 0.59167041 |
| 142 | Colorectal cancer_Homo sapiens_hsa05210 | 0.58836428 |
| 143 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.58746111 |
| 144 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.57785961 |
| 145 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.56126462 |
| 146 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.55546000 |
| 147 | Melanoma_Homo sapiens_hsa05218 | 0.53540148 |
| 148 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53123386 |
| 149 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.52999498 |
| 150 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.52593741 |
| 151 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.52562548 |

